Recombinant Human Erythropoietin Alfa

Dosage Forms Available

• Recombinant Human Erythropoietin Alfa is available for use through the intravenous (in the vein) or subcutaneous (under the skin) routes (injection).

Age and Dose Restrictions

• This medication is suitable for both adults and children, as recommended by the doctor.

Contraindications

• Recombinant Human Erythropoietin Alfa is contraindicated in patients with allergy to any component of the product.

• It is also contraindicated in patients with uncontrolled hypertension.

Other Medications to Avoid

• Recombinant Human Erythropoietin Alfa can interact with antihypertensive medications (such as atenolol and metoprolol).

Overdose and Missed Dose

• Overdose of Recombinant Human Erythropoietin Alfa may lead to an increase in haematocrit levels (percentage of red blood cells), potentially causing thrombotic events (blood clots). Immediate medical attention is required.

• If you miss a dose of this medicine, administer it as soon as possible. However, if it is near the time for the next dose, skip the missed dose and continue with your usual dosing schedule.

Management of Side Effects

Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.

• For managing headaches, try to rest and relax.

• If you experience nausea, eat little and often, and stick to simple meals.

• In case of injection site pain or irritation, try applying a cold pack to the area.

Use in Driving and Operating Machinery

• Recombinant Human Erythropoietin Alfa may cause side effects such as dizziness or fainting. If affected, avoid driving or operating heavy machinery.

Use in Pregnancy and Lactation

• It is advised to consult your doctor before using this medication if you are pregnant or breastfeeding.

Caution in Other Conditions

• Patients with a history of seizures, renal issues, high blood pressure or thrombotic events should exercise caution when using Recombinant Human Erythropoietin Alfa.

• Close monitoring of blood pressure and haematocrit levels is essential for these patients.

Special Dietary and Lifestyle Recommendations

• Stay well hydrated, especially before and after treatment.

• Regular monitoring of blood pressure and blood sugar levels is recommended.